TYCHE INDUSTRIES
|
The Current P/E Ratio of TYCHE INDUSTRIES is 16.35.
| Share Price | ₹106.7 | Mar 18,2026 |
| Market Cap | ₹109.8 Cr | |
| Earnings-TTM | ₹6.7 Cr | TTM-Standalone Results |
| Price/Earnings | 16.35x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of TYCHE INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹109.8 Cr] as on Mar 18,2026
(/) Earnings [ ₹6.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 16.35x ]
Thus, for TYCHE INDUSTRIES , the investors are currently willing to pay 16.35 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TYCHE INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TYCHE INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of TYCHE INDUSTRIES
PE Ratio Performance Analysis for TYCHE INDUSTRIES
- TYCHE INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.94x.
- TYCHE INDUSTRIES 's operated at median p/e ratio of 10.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TYCHE INDUSTRIES 's p/e ratio peaked in Mar2022 at 15.17x.
- TYCHE INDUSTRIES 's p/e ratio hit its five-year low in Mar2021 of 8.74x.
How does TYCHE INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| TYCHE INDUSTRIES | 6.72 | 16.35 | 109.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.79 | 426,782.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 65.80 | 163,125.0 |
| CIPLA LTD | 4,544.70 | 22.54 | 102,443.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.93 | 145,252.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.61 | 108,025.0 |
| MANKIND PHARMA LTD | 1,796.65 | 48.31 | 86,793.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.33 | 90,435.3 |
| LUPIN LTD | 4,669.18 | 22.54 | 105,236.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 20.98 | 73,703.7 |
| ABBOTT INDIA LTD | 1,524.13 | 36.66 | 55,882.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TYCHE INDUSTRIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.35x |
| Max industry PE | 65.80x |
| Median industry PE | 22.54x |
| Average industry PE | 33.99x |
You may also like the below Video Courses